$102 Million is the total value of Asymmetry Capital Management, L.P.'s 36 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MTEM | Exit | MOLECULAR TEMPLATES INC | $0 | – | -1,700 | -100.0% | -0.02% | – |
| TVTY | Exit | TIVITY HEALTH INC | $0 | – | -24,601 | -100.0% | -1.22% | – |
| NVRO | Exit | NEVRO CORP | $0 | – | -13,087 | -100.0% | -1.42% | – |
| PEN | Exit | PENUMBRA INC | $0 | – | -10,279 | -100.0% | -1.49% | – |
| PBYI | Exit | PUMA BIOTECHNOLOGYINC | $0 | – | -18,057 | -100.0% | -1.54% | – |
| ARRY | Exit | ARRAY BIOPHARMA INC | $0 | – | -81,649 | -100.0% | -1.67% | – |
| TCMD | Exit | TACTILE SYSTEMS TECHNOLOGY INC | $0 | – | -42,460 | -100.0% | -1.69% | – |
| INGN | Exit | INOGEN INC | $0 | – | -12,471 | -100.0% | -1.92% | – |
| LJPC | Exit | LA JOLLA PHARMACEUTICAL CO | $0 | – | -55,864 | -100.0% | -2.08% | – |
| BSX | Exit | BOSTON SCIENTIFIC CORP | $0 | – | -68,270 | -100.0% | -2.33% | – |
| PFE | Exit | PFIZER INC | $0 | – | -53,242 | -100.0% | -2.36% | – |
| SNDX | Exit | SYNDAX PHARMACEUTICALS INC | $0 | – | -135,974 | -100.0% | -2.42% | – |
| KALA | Exit | KALA PHARMACEUTICALS | $0 | – | -134,250 | -100.0% | -2.66% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-07
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CENTENE CORP | 21 | Q4 2021 | 10.7% |
| UNITEDHEALTH GROUP INC | 21 | Q4 2021 | 7.2% |
| AMICUS THERAPEUTICS INC | 20 | Q4 2021 | 8.0% |
| PTC THERAPEUTICS INC | 19 | Q3 2021 | 13.8% |
| AERIE PHARMACEUTICALS INC | 16 | Q4 2019 | 9.9% |
| JAZZ PHARMACEUTICALS PLC | 15 | Q2 2021 | 10.2% |
| BIO-RAD LABRATORIES | 13 | Q2 2021 | 6.3% |
| NEVRO CORP | 12 | Q3 2018 | 7.2% |
| NEUROCRINE BIOSCIENCES INC | 12 | Q4 2018 | 6.5% |
| NUCANA PLC-ADR | 12 | Q4 2020 | 2.6% |
View Asymmetry Capital Management, L.P.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-01-19 |
| 13F-HR | 2021-11-04 |
| 13F-HR | 2021-07-28 |
| 13F-HR | 2021-05-11 |
| 13F-HR | 2021-02-11 |
| 13F-HR | 2020-11-12 |
| 13F-HR | 2020-08-06 |
| 13F-HR | 2020-05-13 |
| 13F-HR | 2020-02-12 |
| 13F-HR | 2019-11-12 |
View Asymmetry Capital Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.